XML 56 R62.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measures - Additional Information (Detail) (USD $)
12 Months Ended
Oct. 31, 2012
Oct. 31, 2011
Oct. 31, 2010
Fair Value Measures [Line Items]      
Reduction in research and development expenses $ 3,600,000    
Contingent consideration 800,000    
Other-than-temporary impairment 500,000 1,000,000 500,000
Cost of equity investments sold   2,400,000  
Sale of equity investments   3,200,000  
Gain on sale of equity investments   800,000  
Potential earn out receivable   1,500,000  
Non-marketable equity securities 11,700,000    
Cost-method Investments
     
Fair Value Measures [Line Items]      
Non-marketable equity securities 7,000,000 4,000,000  
Equity Method Investments
     
Fair Value Measures [Line Items]      
Non-marketable equity securities $ 4,700,000